Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus

Archives of Dermatology

Volumn 145, Issue 11, 2009, Pages 1303-1308

  Kreuter, Alexander ^a   Tigges, Christian ^a   Gaifullina, Renata ^a   Kirschke, Julia ^a   Altmeyer, Peter ^a   Gambichler, Thilo ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; METHOTREXATE; MIDDLE AGED; PROBABILITY; PULSE THERAPY, DRUG; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 72749106550     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.235     Document Type: Article

References (24)

1. Howard A, Dean D, Cooper S, Kirtshig G, Wojnarowska F. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas J Dermatol. 2004;45(1):12-15. (Pubitemid 38315843)
2. Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362(9378):118-123. (Pubitemid 36831022)
3. Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008;144(11):1432-1435.
4. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353(9166):1777- 1783.
5. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol. 2004;140(6):709-712. (Pubitemid 38747287)
6. Neill SM, Ridley CM. Management of anogenital lichen sclerosus. Clin Exp Dermatol. 2001;26(8):637-643.
7. Colbert RL, Chiang MP, Carlin CS, Fleming M. Progressive extragenital lichen sclerosus successfully treated with narrowband UV-B phototherapy. Arch Dermatol. 2007;143(1):19-20. (Pubitemid 46143191)
8. Kreuter A, Gambichler T. Narrowband UV-B phototherapy for extragenital lichen sclerosus. Arch Dermatol. 2007;143(9):1213. (Pubitemid 47443387)
9. Kreuter A, Gambichler T. UV-A1 phototherapy for sclerotic skin diseases: implications for optimizing patient selection and management. Arch Dermatol. 2008;144(7):912-916. (Pubitemid 352039744)
10. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol. 2002;46(2):251-255. (Pubitemid 34118383)
11. Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma [published correction appears in Arch Dermatol. 2005;141(9):1091]. Arch Dermatol. 2005;141(7):847-852.
12. Uitto J, Santa Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus: clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol. 1980;3(3):271-279. (Pubitemid 11165545)
13. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol. 1998;39(2, pt 1):220-225. (Pubitemid 28367333)
14. Hengge UR, Krause W, Hofmann H, et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol. 2006;155(5):1021-1028. (Pubitemid 44564514)
15. Oskay T, Sezer HK, Genç C, Kutluay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol. 2007;46(5):527-532. (Pubitemid 46711440)
16. Zulian F. New developments in localized scleroderma. Curr Opin Rheumatol. 2008;20(5):601-607.
17. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000;136(1):91-95. (Pubitemid 30468564)
18. Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol. 2006;155(5):1013-1020. (Pubitemid 44564513)
19. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res. 1995;287(2):193-197.
20. Romero LI, Pincus SH. In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease. Int Arch Allergy Immunol. 1992;99(1):44-49.
21. Kreuter A, Hyun J, Skrygan M, et al. Ultraviolet A1-induced downregulation of human β-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br J Dermatol. 2006;155(3):600-607. (Pubitemid 44215493)
22. Rau R, Herborn G. Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol. 2004;22(5)(suppl 35):S83-S94. (Pubitemid 39334784)
23. Thompson JF, Chalmers DH, Wood RF, Kirkham SR, Morris PJ. Sudden death following high-dose intravenous methylprednisolone. Transplantation. 1983;36(5):594-596.
24. Haajanen J, Saarinen O, Laasonen L, Kuhlbäck B, Edgren J, Slätis P. Steroid treatment and aseptic necrosis of the femoral head in renal transplant recipients. Transplant Proc. 1984;16(5):1316-1319. (Pubitemid 14023591)